Can we predict refractory epilepsy at the time of diagnosis?

Epileptic Disorders

Volumn 7, Issue SUPPL. 1, 2005, Pages

  Semah, Franck ^a,b   Ryvlin, Philippe ^c  

^a DIF   (France)

^b CENTRE HOSPITALIER SAINTE ANNE   (France)

^c UNIVERSITÉ LYON 1   (France)

Author keywords

Epilepsy; MRI; Prognosis; Risk factor; Syndrome; Treatment

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; ANTICONVULSIVE AGENT; GLYCOPROTEIN P; LAMOTRIGINE; MULTIDRUG RESISTANCE PROTEIN 1; VALPROIC ACID;

AMINO ACID SUBSTITUTION; BRAIN INJURY; CENTRAL NERVOUS SYSTEM MALFORMATION; CONFERENCE PAPER; DNA POLYMORPHISM; EPILEPSY; EPILEPTOGENESIS; HIPPOCAMPAL SCLEROSIS; HUMAN; IDIOPATHIC DISEASE; MYOCLONUS EPILEPSY; NEUROIMAGING; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; SEIZURE; TEMPORAL LOBE EPILEPSY;

DRUG RESISTANCE; EPILEPSY; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; PROGNOSIS; SYNDROME; TEMPORAL LOBE;

EID: 25844502084     PISSN: 12949361     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (34)

1. Berg AT, Langfitt J, Shinnar S, et al. How long does it take for partial epilepsy to become intractable? Neurology 2003; 60: 186-90.
2. Berg AT, Levy SR, Novotny EJ, Shinnar S. Predictors of intractable epilepsy in childhood: a case-control study. Epilepsia 1996; 37: 24-30.
3. Berg AT, Shinnar S, Levy SR, et al. Early development of intractable epilepsy in children: a prospective study. Neurology 2001; 56: 1445-52.
4. Berg AT, Shinnar S. The risk of seizure recurrence following a first unprovoked seizure: A quantitative review. Neurology 1991; 41: 965-72.
5. Camfield CS, Camfield PR, Gordon KE, Dooley JM. Does the number of seizures before treatment influence ease of control or remission of childhood epilepsy? Not if the number is 10 or less. Neurology 1996; 46: 41-4.
6. Cockerell OC, Johnson AL, Sander JWAS, Shorvon SD. Prognosis of epilepsy: a review and further analysis of the first nine years of the British National General Practice Study of Epilepsy, a prospective population-based study. Epilepsia 1997; 38: 31-46.
7. Dlugos DJ, Sammel MD, Strom BL, Farrar JT. Response to first drug trial predicts outcome in childhood temporal lobe epilepsy. Neurology 2001; 57: 2259-64.
8. Elwes RDC, Johnson AL, Shorvon SD, Reynolds EH. The prognosis for seizure control in newly diagnosed epilepsy. N Engl J Med 1984; 311: 944-7.
9. Gambardella A, Manna I, Labate A, et al. GABA(B) receptor 1 polymorphism (G1465A) is associated with temporal lobe epilepsy. Neurology 2003; 60: 560-3.
10. Gelisse P, Genton P, Thomas P, et al. Clinical factors of drug resistance in juvenile myoclonic epilepsy. J Neurol Neurosurg Psychiatry 2001; 70: 240-3.
11. Hart YM, Sander JWAS, Johnson AL, Shorvon SD. National general practice study of epilepsy: recurrence after a first seizure. Lancet 1990; 336: 1271-4.
12. Hauser WA, Rich SS, Annegers JF, Anderson VE. Seizure recurrence after a 1st unprovoked seizure: an extended follow-up. Neurology 1990; 40: 1163-70.
13. Hauser WA, Rich SS, Lee JR, Annegers JF, Anderson VE. Risk of recurrent seizures after two unprovoked seizures. N Engl J Med 1998; 338: 429-34.
14. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med 2000; 342: 314-9.
15. Lamy C, Domigo V, Semah F, et al. Early and late seizures after cryptogenic ischemic stroke in young adults. Neurology 2003; 60: 400-4.
16. MaS, Abou-Khalil B, SutcliffeJS, Haines JL, Hedera P. The GABBR1 locus and the G1465A variant is not associated with temporal lobe epilepsy preceded by febrile seizures. BMC Med Genet 2005; 6: 13.
17. MacDonald BK, Johnson AL, Goodridge DMG, et al. Factors predicting prognosis of epilepsy after presentation with seizures. Ann Neurol 2000; 48: 833-41.
18. Marson A, Jacoby A, Johnson A, Kim L, Gamble C, Chadwick D, Medical Research Council MESS Study Croup. Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomised controlled trial. Lancet 2005; 28(365): 2007-13.
19. Mattson RH, Cramer JA, Collins JF, The Department of Veterans Affairs Epilepsy Cooperative Studies No. 118 and No.264 Group. Prognosis for total control of complex partial and secondarily generalized tonic-clonic seizures. Neurology 1996; 47: 68-76.
20. Musicco M, Beghi E, Solari A, Viani F. Treatment of first tonic-clonic seizure does not improve the prognosis of epilepsy. First Seizure Trial Group (FIRST Group). Neurology 1997; 49: 991-8.
21. Prasad A, Kuzniecky RI, Knowlton RC, et al. Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy. Arch Neurol 2003; 60: 1100-5.
22. Salzmann A, Moulard B, Crespel A, Baldy-Moulinier M, Buresi C, MalafosseA. GABA receptor 1 polymorphism (G 1465A) and temporal lobe epilepsy. Epilepsia 2005; 46: 931-3.
23. Sander JWAS. Some aspects of prognosis in the epilepsies: a review. Epilepsia 1993; 34: 1007-16.
24. Semah F, Lamy C, Demeret S. Hippocampal sclerosis and other hippocampal abnormalities in the early identification of candidates for epilepsy surgery. Arch Neurol 2002; 59: 1042-3.
25. Semah F, Picot MC, Adam C, et al. Is the underlying cause of epilepsy a major prognostic factor for recurrence? Neurology 1998; 51: 1256-62.
26. Siddiqui A, Kerb R, Weale ME, et al. Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1. N Engl J Med 2003; 348: 1442-8.
27. Sillanpää M. Remission of seizures and predictors of intractability in long-term follow-up. Epilepsia 1993; 34: 930-6.
28. Sills GJ, Mohanraj R, Butler E, et al. Lack of association between the C3435T polymorphism in the human multidrug resistance (MDRI) gene and response to antiepileptic drug treatment. Epilepsia 2005; 46: 643-7.
29. Stephen LJ, Kwan P, Brodie MJ. Does the cause of localisation-related epilepsy influence the response to antiepileptic drug treatment? Epilepsia 2001; 42: 357-62.
30. Tan NC, Heron SE, Scheffer IE, Berkovic SF, Mulley JC. Is variation in the GABA(B) receptor 1 gene associated with temporal lobe epilepsy? Epilepsia 2005; 46: 778-80.
31. Tan NC, Heron SE, Scheffer IE, et al. Failure to confirm association of a polymorphism in ABCB1 with multidrug-resistant epilepsy. Neurology 2004; 63: 1090-2.
32. Van Paesschen W, Duncan JS, Stevens JM, Connelly A. Etiology and early prognosis of newly diagnosed partial seizures in adults: a quantitative hippocampal MRI study. Neurology 1997; 49: 753-7.
33. Wolf P, Inoue Y. Juvenile absence epilepsy. In: Roger J, Bureau M, Dravet C, Genton P, Tassinari CA, Wolf P, eds. Epileptic syndromes in infancy, childhood and adolescence. Eastleigh, UK: John Libbey, 2002: 331-4.
34. Zimprich F, Sunder-Plassmann R, Stogmann E, et al. Association of an ABCB1 gene haplotype with pharmacoresistance in temporal lobe epilepsy. Neurology 2004; 63: 1087-9.